Argenx says its drug Vyvgart looks promising in two more autoimmune diseases
The Dutch biotech argenx has big plans for its autoimmune disease drug Vyvgart, which is approved for three conditions and being tested in a dozen more. On Tuesday evening, it announced new ...
The Dutch biotech argenx has big plans for its autoimmune disease drug Vyvgart, which is approved for three conditions and being tested in a dozen more. On Tuesday evening, it announced new ...
